Home
Sessions
PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology
Phase I HyDEF Trial: Hypofractionated and Dual Equivalent Fractionated Bridging Radiation Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Undergoing T-Cell Redirection Therapy

Sep 28

PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology

3806 - Phase I HyDEF Trial: Hypofractionated and Dual Equivalent Fractionated Bridging Radiation Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Undergoing T-Cell Redirection Therapy

03:00pm - 04:00pm ET

Presenter(s)

Alisa Rybkin, MD, MPH - Yale Medicine, New Haven, CT